Inventor · disambiguated record
Michael J. Leach
Also filed as: LEACH MICHAEL · LEACH MICHAEL J · LEACH MICHAEL JOHN
19 granted patents·9 pending applications·144 citations·filing 1995–2016
95Inventor score
Top patents by PatentIndex Score
28 records- 0182US8691818B2Cyclic triazo and diazo sodium channel blockersLEACH MICHAEL·Filed 2009·Granted Apr 8, 2014·6 cites·7 claims
- 0281US8268823B2Medical use of triazine derivativesLEACH MICHAEL·Filed 2007·Granted Sep 18, 2012·6 cites·4 claims
- 0381US7935729B2Use of triglyceride oils containing γ-linolenic acid residues and linoleic acid residues for the treatment of neurodegenerative diseaseBTG INT LTD·Filed 2004·Granted May 3, 2011·18 cites·34 claims
- 0480US8748599B2Cyclic triazo sodium channel blockersLEACH MICHAEL·Filed 2010·Granted Jun 10, 2014·5 cites·18 claims
- 0579US8748600B2Cyclic triazo sodium channel blockersLEACH MICHAEL·Filed 2010·Granted Jun 10, 2014·6 cites·24 claims
- 0677US9000155B2Cyclic triazo sodium channel blockersUNIV GREENWICH·Filed 2014·Granted Apr 7, 2015·3 cites·21 claims
- 0775US5597827ATreatment of injury of the spinal cord or brain using 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidineGLAXO WELLCOME INC·Filed 1995·Granted Jan 28, 1997·22 cites·11 claims
- 0874US10576086B2Triazine derivatives as interferon-gamma inhibitorsUNIV GREENWICH·Filed 2016·Granted Mar 3, 2020·2 cites·18 claims
- 0972US9862691B2Cyclic triazo and diazo sodium channel blockersUNIV GREENWICH·Filed 2016·Granted Jan 9, 2018·1 cites·20 claims
- 1070US9422253B2Cyclic triazo and diazo sodium channel blockersUNIV GREENWICH·Filed 2014·Granted Aug 23, 2016·1 cites·14 claims
- 1170US5597828ACertain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which are pharmacologically active CNS compoundsGLAXO WELLCOME INC·Filed 1995·Granted Jan 28, 1997·17 cites·18 claims
- 1266US5591746ATreatment of damage from a stroke using 4-amino(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidineGLAXO WELLCOME INC·Filed 1995·Granted Jan 7, 1997·13 cites·12 claims
- 1365US2010113810A1Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2009·Application pending·0 cites
- 1464US2010113595A1Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2009·Application pending·0 cites
- 1561US5587380ACertain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines which are pharmacologically active CNS compoundsGLAXO WELLCOME INC·Filed 1995·Granted Dec 24, 1996·10 cites·20 claims
- 1657US7964641B2Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2004·Granted Jun 21, 2011·0 cites·4 claims
- 1757US5684005APharmacologically active CNS compoundsGLAXO WELLCOME INC·Filed 1995·Granted Nov 4, 1997·8 cites·23 claims
- 1856US5635507APharmacologically active CNS compoundsGLAXO WELLCOME INC·Filed 1995·Granted Jun 3, 1997·7 cites·12 claims
- 1953US5712277AUse of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for the treatment of pain and oedemaGLAXO WELLCOME INC·Filed 1996·Granted Jan 27, 1998·13 cites·8 claims
- 2052US5712276A2-(n-alkylpiperazino or morpholino)-4-amino-5-aryl-pyrimidinesGLAXO WELLCOME INC·Filed 1995·Granted Jan 27, 1998·6 cites·20 claims
- 2150US2004229873A1Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2004·Application pending·0 cites
- 2247US2012142775A1Treatment of neurodegenerative conditionsHARBIGE LAURENCE S·Filed 2012·Application pending·0 cites
- 2347US2013005732A1New medical use of triazine derivativesUNIV GREENWICH·Filed 2012·Application pending·0 cites
- 2443US2009023807A1Treatment of Cytokine Dysregulation by Using Sn-2 Gamma-Linolenoyl, Gamma-Diho-Molinolenoyl or Arachidonoyl Patty Acid Glycerol MonoestersBTG INT LTD·Filed 2006·Application pending·0 cites
- 2542US2011184063A1Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2011·Application pending·0 cites
- 2640US2009137660A1Cytokine Modulators Using Cyclic Glycerides of Essential Polyunsaturated Fatty AcidsHARBIGE LAURENCE S·Filed 2006·Application pending·0 cites
- 2740US2009036410A1Structured PhospholipidsBTG INT LTD·Filed 2005·Application pending·0 cites
- 2838US8114903B2Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acidsHARBIGE LAURENCE S·Filed 2010·Granted Feb 14, 2012·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Michael J. Leach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →